The basis for the chemopreventive action of resveratrol

Drugs of Today

Volumn 38, Issue 8, 2002, Pages 571-580

  Roemer, Klaus ^a   Mahyar Roemer, Mojgan ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; PROSTAGLANDIN SYNTHASE; RESVERATROL;

ANTINEOPLASTIC ACTIVITY; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; CELL SURVIVAL; CYTOSTASIS; DNA SYNTHESIS; DRUG MECHANISM; DRUG METABOLISM; HUMAN; INFLAMMATION; LIPID METABOLISM; REVIEW; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARDIOVASCULAR DISEASES; HUMANS; NEOPLASMS; STILBENES;

EID: 0036695546     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2002.38.8.820097     Document Type: Review

References (63)

1. The production of resveratrol by Vitis vinifera and other members of the Vitacae as a response to infection or injury
2. Measurement of trans-resveratrol, (+)-catechin, and quercetin in rat and human blood and urine by gas chromatography with mass selective detection
3. Resveratrol, a natural polyphenolic compound: Interactions with proteins and cell uptake
4. Plasma and tissue resveratrol concentrations and pharmacological activity
5. Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. A paradox
6. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
7. Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcintype structure
8. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells
9. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines
10. Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests
11. Effects of stilbenes isolated from medicinal plants on arachidonate metabolism and degranulation in human polymorphonuclear leukocytes
12. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease
13. Inhibition of human LDL oxidation by resveratrol
14. Biological effects of resveratrol
15. Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2
16. Absorption of trans-resveratrol in rats
17. More on antioxidant activity of resveratrol in red wine
18. Wines and grape juices as modulators of platelet aggregation in healthy human subjects
19. Mortality associated with moderate intakes of wine, beer, and spirits
20. Gas chromatographic analysis of resveratrol in plasma, lipoproteins and cells after in vitro incubations
21. Alcohol and mortality in middle-aged men from eastern France
22. Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model
23. Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting Bax and p21(CIP) expression
24. Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis
25. The effects of resveratrol on CYP1A1 expression and aryl hydrocarbon receptor function in vitro
26. Resveratrol induces colon tumor cell apoptosis independently of p53 and precede by epithelial differentiation, mitochondrial proliferation and membrane potential collapse
27. Resveratrol inhibits the proliferation of normal human keratinocytes in vitro
28. Resveratrol selectively inhibits leukemia cells: A prospective agent for ex vivo bone marrow purging
29. Differential response of immature rat uterine tissue to ethinylestradiol and the red wine constituent resveratrol
30. Partial and weak oestrogenicity of the red wine constituent resveratrol: Consideration of its superagonist activity in MCF-7 cells and its suggested cardiovascular protective effects
31. Resveratrol inhibits human breast cancer cell growth and may mitigate the effect of linoleic acid, a potent breast cancer cell stimulator
32. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor
33. Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol
34. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models
35. Apoptosis: A link between cancer genetics and chemotherapy
36. Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase
37. Involvement of c-jun NH(2)-terminal kinases in resveratrol-induced activation of p53 and apoptosis
38. Disruption of p53 in human cancer cells alters the responses to therapeutic agents
39. p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents
40. Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway
41. Resveratrol analog, 3,4,5,4′-tetrahydroxystilbene, differentially induces pro-apoptotic p53/Bax gene expression and inhibits the growth of transformed cells but not their normal counterparts
42. Induction of apoptosis by 3,4′-dimethoxy-5-hydroxystilbene in human promyeloid leukemic HL-60 cells
43. Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53
44. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells
45. Resveratrol induces Fas signalling-independent apoptosis in THP-1 human monocytic leukaemia cells
46. Resveratrol, a tumor-suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl-2
47. Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis
48. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IB kinase
49. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF- B, activator protein-1, and apoptosis: Potential role of reactive oxygen intermediates and lipid peroxidation
50. p38 MAP kinase mediates Bax translocation in nitric oxide-induced apoptosis in neurons
51. Resveratrol inhibits phorbol ester and UV-induced activator protein 1 activation by interfering with mitogen-activated protein kinase pathways
52. Resveratrol-induced inactivation of human gastric adenocarcinoma cells through a protein kinase C-mediated mechanism
53. Resveratrol, a remarkable inhibitor of ribonucleotide reductase
54. DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia
55. Resveratrol induces prostate cancer cell entry into s phase and inhibits DNA synthesis
56. Resveratrol arrests the cell division cycle at S/G2 phase transition
57. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells
58. Chemopreventive agent resveratrol, a natural product derived from grapes, reversibly inhibits progression through S and G2 phases of the cell cycle in U937 cells
59. Genistein, a specific inhibitor of tyrosine-specific protein kinases
60. Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells
61. Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic dancer cells
62. Anti-proliferative effect of synthetic resveratrol on human breast epithelial cells
63. Inhibitory effect of resveratrol on the proliferation of human and rat hepatic derived cell lines